Quick search:
Content Search
Result Content Research
Result Content Research
1 Pediatric Achalasia
2 Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19 | NEJM
3 Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents | NEJM
4 Is It Finally Time for a Medicare Dental Benefit? | NEJM
5 REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19 | NEJM
6 Uncomfortable Truths — What Covid-19 Has Revealed about Chronic-Disease Care in America
7 Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines | NEJM
8 BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant | NEJM
9 Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage | NEJM
10 Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
11 Integrating Research into Community Practice — Toward Increased Diversity in Clinical Trials | NEJM
12 Myocarditis after Covid-19 Vaccination in a Large Health Care Organization | NEJM
13 Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19 | NEJM
14 AQP1 Variant and Peritoneal Dialysis
15 Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
16 Spinal Anesthesia or General Anesthesia for Hip Surgery in Older Adults
17 SARS-CoV-2 Infection among Nursing Home Residents
18 Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
19 Obesity-Associated GNAS Mutations and the Melanocortin Pathway
20 Convalescent Plasma for Outpatients with Covid-19
21 Covid-19 Breakthrough Infections in Vaccinated Health Care Workers | NEJM
22 SARS-CoV-2 Human Challenge Studies
23 Intervention Timing for Infected Necrotizing Pancreatitis | NEJM
24 Eric Rubin, Renee Salas elected to National Academy of Medicine
25 Virchow at 200 and Lown at 100 — Physicians as Activists | NEJM
26 Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM
27 Test Scores < Yale School of Medicine
28 Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors
29 Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting | NEJM
30 Race in Medicine — Genetic Variation, Social Categories, and Paths to Health Equity | NEJM
31 Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents | NEJM
32 Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines | NEJM
33 Revitalizing the US Primary Care Infrastructure
34 Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons | NEJM
35 BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting | NEJM
36 SARS-CoV-2 Variants in Patients with Immunosuppression
37 Effect of Salt Substitution on Cardiovascular Events and Death
38 SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3 | NEJM
39 Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine | NEJM
40 SARS-CoV-2 Variants and Vaccines | NEJM
41 Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce
42 Surviving Covid-19 with Heparin? | NEJM
43 Breathless
44 Empagliflozin in Heart Failure with a Preserved Ejection Fraction | NEJM
45 Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
46 Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination
47 Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients | NEJM
48 Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM
49 Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis | NEJM
50 Vigilante Injustice — Deputizing and Weaponizing the Public to Stop Abortions | NEJM
51 Inside and Out
52 I Can't Breathe during Interviews — The Incomplete Penetrance of Antiracism
53 Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia | NEJM
54 Immunotherapy for MIS-C — IVIG, Glucocorticoids, and Biologics | NEJM
55 Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention
56 MRNA Covid-19 Vaccines in Pregnant Women
57 Efficacy of Wolbachia-Infected Mosquito Deployments for the Control of Dengue | NEJM
58 Race, Genetic Ancestry, and Estimating Kidney Function in CKD | NEJM
59 Abelacimab for Prevention of Venous Thromboembolism
60 Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination | NEJM
61 Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation | NEJM
62 The Pathophysiology of Racial Disparities
63 Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings | NEJM
64 Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes | NEJM
65 Long-Term Complications in Youth-Onset Type 2 Diabetes | NEJM
66 A Large, Simple Trial Leading to Complex Questions
67 Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents | NEJM
68 Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer | NEJM
69 Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 | NEJM
70 Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
71 Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center
72 Decline in Pathogenic Antibodies over Time in VITT | NEJM
73 Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer | NEJM
74 Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
75 Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization
76 Private Equity and Physician Medical Practices — Navigating a Changing Ecosystem | NEJM
77 Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock | NEJM
78 Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest | NEJM
79 Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
80 Trends in Diabetes Treatment and Control in US Adults, 1999–2018
81 Identifying and Tracking SARS-CoV-2 Variants — A Challenge and an Opportunity | NEJM
82 Covid-19 Vaccine Resources
83 A Hidden Opportunity — Medicaid's Role in Supporting Equitable Access to Clinical Trials | NEJM
84 MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
85 Trials: COVID vaccines 90% effective against Delta infection, death
86 Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia | NEJM
87 A Monoclonal Antibody for Malaria Prevention | NEJM
88 Household Transmission of SARS-CoV-2 from Children and Adolescents | NEJM
89 Breakthrough SARS-CoV-2 Infections in Prison after Vaccination | NEJM
90 Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM
91 BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants | NEJM
92 CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
93 Contact Tracing for Covid-19 — A Digital Inoculation against Future Pandemics | NEJM
94 Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM
95 Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination | NEJM
96 New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
97 Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study
98 Donanemab in Early Alzheimer's Disease | NEJM
99 Optogenetics — The Might of Light
100 Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes